A focal adhesion kinase-YAP signaling axis drives drug tolerant persister cells and residual disease in lung cancer
Franziska Haderk(Boehringer Ingelheim (Germany)), Trever G. Bivona(University of California, San Francisco), Collin M. Blakely(City College of San Francisco), Oghenekevwe M. Gbenedio(University of California, San Francisco), Bo Huang(University of California, San Francisco), Mourad Majidi(The University of Texas MD Anderson Cancer Center), Shigeki Nanjo(Kanazawa University Hospital), Khyati N. Shah(Pfizer (United States)), Ismail M. Meraz(The University of Texas MD Anderson Cancer Center), Jack A. Roth(The University of Texas MD Anderson Cancer Center), Sourav Bandyopadhyay(University of California, San Francisco), Lauren Čech(University of California, San Francisco), Caroline E. McCoach(Memorial Sloan Kettering Cancer Center), J. Silvio Gutkind(National Institutes of Health), Johnny Yu(University of California, San Francisco), Pilar Santisteban(Instituto de Investigaciones Biomédicas Sols-Morreale), Julia Rotow(University of California, San Francisco), Victor Olivas(University of California, San Francisco), Whitney Tamaki(University of California, San Francisco), Calvin J. Kuo(Stratford University), Jeroen P. Roose(University of California, San Francisco), Kari A. Herrington(University of California, San Francisco), Tracy Tang(Bristol-Myers Squibb (United States)), David V. Allegakoen(University of California, San Francisco), Celia Fernández-Méndez(Consejo Superior de Investigaciones Científicas), Jonathan W. Riess(University of California Davis Medical Center), Hani Goodarzi(Rockefeller University), Dora Barbosa Rabago(University of California, San Francisco), Leonard Post, D. Lucas Kerr(UCSF Helen Diller Family Comprehensive Cancer Center), Wei Wu(Children's Hospital of Zhejiang University), Juan Guan(University of California, San Francisco), Carlos F. Gómez(University of California, San Francisco)
Cited by 18
Related Papers
Oncogenic Signaling Pathways in The Cancer Genome Atlas
|Cell|2018|3.4k
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|1.4k
A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development
|The Journal of Experimental Medicine|2006|1.3k
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%
|Journal of Clinical Oncology|2021|1.1k
The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization
|Proceedings of the National Academy of Sciences|2004|1.1k